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Observations of glomerular epithelial cell structure in patients with
type I diabetes mellitus. Overt proteinuria is a hallmark of diabetic
nephropathy while microalbuminuria is thought to be a predictor of
later onset of diabetic nephropathy. Yet the mechanisms for abnormal
urinary protein leak in diabetes have not been defined. We studied 28
patients with type I diabetes for 7 to 33 years. Creatinine clearance,
urinary albumin excretion rate (UAE), and multiple blood pressures
were obtained in each patient. A renal biopsy was performed in each
patient and in 28 normal subjects, Quantitative stereology was used to
determine foot process (FP) width, filtration slit length density (FSLv)
and filtration slit length/glomerulus (FSLG). FP width was slightly wider
than normal in diabetic patients with UAE <250 mg124 hr while FP was
significantly wider than both of these groups in diabetics with UAE >
250 mg/24 hr. FSLv and FSLG were similar in normals and diabetics
with UAE < 250 mg/24 hr but both were reduced in diabetics with UAE
> 250 mg/24 hr. UAE correlated with FP width (P < 0.05), FSL0 (P <
0.01) and most precisely and FSLv (P < 0.001). Diabetics with
microalbuminuria had values for all the structural parameters measured
here not different from diabetics with UAE in the normal range.
Perturbations of epithelial cell structure are present in diabetes mellitus
especially in patients with nephropathy. The exact relationships be-
tween albuminuria and epithelial cell structure remains to be elucidated.
Overt diabetic nephropathy is typically ushered in by the
development of dipstick—positive proteinuria and then pro-
gresses through hypertension and declining glomerular filtration
rate (GFR) to terminal uremia [1—3]. Microalbuminuria (in-
creased urinary albumin excretion below the range of detect-
ability by standard laboratory tests) is a strong predictor of the
later development of overt diabetic nephropathy [4—7]. Thus,
proteinuria is an important subject for study in the diabetic
patient. Yet, the mechanisms for microalbuminuria and overt
proteinuria in diabetes remain unclear and precise renal struc-
tural correlates of the abnormal albumin leakage have not been
defined.
Since protein leakage in patients with minimal change ne-
phrotic syndrome [8] and in animals with experimental ne-
phrotic syndrome [9] has been associated with demonstrable
widening of the glomerular epithelial foot processes, and since
GFR is inversely correlated to foot process width in minimal
change nephrotic patients [8], we investigated whether epithe-
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hal cell structural parameters were related to albuminuria and
GFR in type I diabetes mellitus.
Methods
Twenty-eight patients aged 20 to 55 years (31 7 years, X
SD) with type I diabetes mellitus for 7 to 33 years (19 6 years)
were studied in the Clinical Research Center at the University
of Minnesota. All patients were evaluated as possible candi-
dates for pancreas transplantation. These patients represent a
subset of patients previously reported by us [10, 11]; in the
current study we evaluated all patients who had adequate
numbers of glomeruli available on renal biopsy for glomerular
volume determination as well as urine specimens available for
fluorometric albumin assay. All studies were approved by the
Committee on the Use of Human Subjects in Research at the
University of Minnesota and each subject gave informed con-
sent. Each patient had two or three 24-hour urine collections
completed for measurement of creatinine clearance (Car) by
standard laboratory techniques and urinary albumin excretion
rate (UAE) measured by fluorometric immunoassay [12]. These
measurements were averaged and expressed as ml/min for Ccr
and mg/24 hr for UAE. Each patient had multiple blood
pressure determinations taken during their CRC hospitaliza-
tion. Patients were considered hypertensive if their blood
pressures were regularly greater than 140/90 or if they were
taking anti-hypertensive medication; 9 patients were labeled as
hypertensive. Creatinine clearance ranged from 35 to 157
mllmin while UAE ranged from 3 to 3600 mg/24 hours. Serum
creatinine was less than 2.4 mg/dl in all patients. Patients were
defined as having microalbuminuria if their UAE was 30 to 250
mg/24 hr; 5 patients were so defined. Patients were defined as
having clinical diabetic nephropathy if they had two or more of
the following: Cr less than 95 mI/mm; UAE greater than 250
mg/24 hr; or hypertension. Eight patients fulfilled the criteria for
clinical nephropathy (Table 1). One patient had mild hyperten-
sion but no other findings of clinical nephropathy.
Each diabetic patient underwent a percutaneous renal bi-
opsy. In addition, 28 normal people aged 24 to 52 years (33 8
years) serving as living—related kidney donors had kidney
biopsies performed at the time of donation for transplantation
[131. Other structural values for these normal people are re-
ported elsewhere [13]. All biopsy specimens were immediately
examined under a dissecting microscope to insure that glomer-
uli were present. One part of the tissue was placed in Zenker's
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fixative, washed, embedded in paraffin, and processed by usual
laboratory techniques for light microscopy. The other part of
the tissue was cut into approximately 1 mm cubes and placed in
2.5% glutaraldehyde in 0.17 M cacodylate buffer and prepared
for electron microscopy as previously described [10, 111.
Thick (1 Lm) sections were cut from each EM block, stained
with toluidine blue, and used for selection of the centermost
glomerulus of each block in which the entire profile was at least
1 tubular diameter from the edge of the block. Three such
glomeruli were selected from each biopsy for thin sectioning.
The thin sections were stained with uranyl acetate and lead
citrate for examination with a JEOL 100 CX electron micro-
scope (JEOL, Tokyo, Japan). Each glomerulus was entered
randomly and electron micrographs were taken systematically
throughout the glomerulus. A carbon replica grating (28,800
lines/inch, E.F. Fullam, Inc., Schenectadey, New York, USA)
was photographed with each glomerulus to determine final
magnification. Foot process width, filtration slit length density,
and glomerular basement membrane width were measured on
electron micrographs with an approximate final magnification of
x 18,000 while all other measurements were completed on
electron micrographs with an approximate final magnification of
x 6000.
Average glomerular volume was determined on light micro-
scopic sections using the method of Hirose and coworkers [14]
where average glomerular area is first measured by point
counting and mean glomerular volume is then calculated. To
insure that each glomerulus was measured only once, only
sections that were at least 100 m apart were examined. Each
biopsy had at least 20 glomeruli available for examination and
the number examined averaged 50 glomeruli (range: 23 to 126
glomeruli).
Glomerular basement membrane (GBM) width and foot proc-
ess width were determined by the orthogonal intercept method
[15]. The width of the epithelial foot processes was determined
along the peripheral GBM only. Each foot process which fell
within an unbiased counting frame was classified using a log
reciprocal scale [16]. The number of foot processes in each
class was used to calculate the harmonic mean foot process
width and multiplied by 8/(3ir) to give the actual mean foot
process width in nanometers [15, 16]. All filtration slits (Q)that
fell within the same unbiased counting frame were counted to
determine filtration slit length density (Lv) [8, 17]:
where
2xQL =
k2 x
k = distance between points on the counting frame (in m)
magnification
and P = number of points failing on the glomerulus.
The filtration slit length density is a mathematical representa-
tion of the length of filtration slit available per reference
volume, in this case the glomerulus.
The volume density of the mesangium and the surface density
of the peripheral capillary filtration surface were determined by
point and intercept counting using standard stereologic tech-
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Table 1. Patient characteristics
Age
Duration of
diabetes Ccr UAE
Foot
process
Years Years mI/mm mg/24 hr Hypertension width nm
Filtration
slit length
density
Filtration
slit length
-
x l03.tm
26 16 59 3600 yes 366 0.20 247
23730 14 70 1476 yes 429 0.09
37138 22 81 1276 yes 308 0.15
31026 22 60 831 yes 338 0.22
39930 20 135 691 yes 405 0.25
16935 28 35 652 yes 391 0.08
18430 12 91 578 yes 492 0.12
69130 23 154 203 no 307 0.34
22 11 113 179 no 371 0.29
24 23 61 136 yes 356 0.29
48637 21 78 73 no 364 0.36
29 18 94 40 no 297 0.23 316
31 21 102 27 no 279 0.35
27 10 122 27 no 354 0.40
23 17 157 26 no 399 0.26 736
24 14 125 24 no 289 0.41 691
20 9 136 21 no 284 0.43 645
25 IS 112 19 yes 288 0.34 65640941 21 134 14 no 383 0.28
40 22 154 12 no 298 0.36 805
26 22 85 12 no 327 0.31 351
33 20 124 10 no 363 0.40 707
36 27 122 8 no 299 0.51 1013
31 20 115 7 no 382 0.35 550
26 7 113 7 no 379 0.38 285
55 33 95 6 no 297 0.34 521
39
34
22
14
109
99
5
3
no
no
374
289
0.41
0.62
412
1061
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niques [10, 11, 171. The per glomerulus mesangial volume,
peripheral capillary filtration surface area, and filtration slit
length were calculated from the glomerular density measures
and mean glomerular volume [11]. The individual values for
mesangial volume/glomerulus and capillary filtration surface!
glomerulus are identical to those reported previously [111.
Statistical analysis
Relationships between variables were assessed by linear
regression using the method of least squares and by multiple
regression analysis. Differences among groups of patients were
assessed by analysis of variance. Results are expressed a mean
standard deviation. Values of P < 0.01 were considered
significant while values of P < 0.05 were considered borderline,
these criteria taking into account the number of analysis per-
formed.
Results
Epithelial foot process width, filtration slit length density and
total filtration slit lengthlglomerulus in the normal subjects
averaged 304 29 nm, 0.41 0.10 jtmItm3, and 576 240 X
l0 m respectively (Fig. 1). Foot processes were slightly wider
than the normals in the diabetic patients with UAE < 250 mg/24
hours averaging 332 41 nm, although this difference did not
reach statistical significance (P <0.05). Diabetic patients with
UAE > 250 mg124 hours had even wider foot processes
averaging 390 61 nm (P < 0.001) compared to either normals
or diabetic subjects with UAE <250 mg/24 hr (Fig. 1). Diabetic
patients with UAE < 250 mg/24 hr did not differ from normal
subjects in filtration slit length density or total filtration slit
length. Diabetic patients with UAE > 250 mg/24 hr had signif-
icantly reduced filtration slit length density (P < 0.001) and total
filtration slit length (P < 0.001) compared to diabetics with
UAE < 250 mg124 hour or normal subjects. Diabetics with
microalbuminuria (that is, UAE 30 to 250 mg/24 hr) had values
of foot process width, filtration slit length density, and filtration
slit length which were no different from diabetics with normal
UAE (Fig. 1).
In the diabetic patients. the log of UAE tended to correlate
directly with foot process width (r = +0.41, P < 0.05) and did
correlate significantly with total filtration slit length/glomerulus
(r =
—0.53, P < 0.01) (Fig. 2, 3). However, the relationship
between filtration slit length density and albuminuria was much
more precise (r = —0.80, P < 0.001, Fig. 4). Creatinine
clearance correlated directly with filtration slit length density (r
+0.49, P < 0.01) and total filtration slit length/glomerulus (r
+0.58, P < 0.001) but not with foot process width (r =
— 0.21, NS). As clearly expected, filtration slit length!
glomerulus was highly correlated with peripheral capillary
filtration surface/glomerulus (r +0.77, P < 0.001). Thus,
similar to our previous studies with peripheral capillary filtra-
tion surface [11], filtration slit length!glomerulus correlated
highly with both total mesangiuin/glomerulus and glomerular
volume together (r = +0.81, P < 0.001).
Discussion
We have previously considered [10, 11] that the diabetic
patients we have studied may not be a precise cross—sectional
representation of renal complications in type I diabetes since
generally they have had difficulty in diabetes management or
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have manifested one or more of the major complications of
diabetes. However, these patients do represent a broad spec-
trum of renal structural and functional parameters [10, 11] and
thus, there is no reason to doubt the validity of the relationships
between renal function and structure in these studies. The
fluorometric method of measuring urinary albumin is reproduc-
ible over a wide range of UAE and is both sensitive and precise
[12]. Creatinine clearances in diabetic patients with GFR in the
range reported here when carefully performed, provide results
which are highly correlated with GFR as measured by inulin
clearance [11,18] and plasma disappearance or5 'Cr-EDTA [19].
The foot process width in our normal subjects averaged 304
29 nm, larger than the value of 224 nm previously reported by
Gundersen and coworkers using the same stereologic methods
[16]. However, we studied 28 normals while only 5 were
evaluated in the previous work [16]. The five normals evaluated
by Gundersen, Seefelt and Osterby were aged 12 to 28 years,
while our normal patients averaged 28 years of age (range 24 to
52 years). Further, in another study with 11 patients designated
as normal who had kidneys surgically removed for tumors, foot
process width using these same stereologic methods averaged
296 nm [20]. Thus, mean foot process width appears to be about
300 nm in normal adult man. It should be pointed out that
assumptions made in the quantitation of foot process width are
clearly inexact. The expression of a mean value for foot process
width belies the fact that the epithelial cell has primary,
secondary and tertiary extensions whose size by qualitative
scanning electron microscopy are orders of magnitude different
[21]. The harmonic mean used here and elsewhere reduces but
does not eliminate the problem that foot process width is not
normally distributed.
Nonetheless, qualitative expansion of foot processes is well
documented in a variety of proteinuric human and experimental
renal diseases. It has been argued that the negative charge of
the sialic acid coat of the epithelial cell, together with intracel-
lular actin filaments probably maintain normal structure of the
foot processes, and that loss of this negative charge results in
fusion of foot processes and obliteration of slit diaphragms [221.
Epithelial cell foot process widening has been quantitatively
documented in minimal change nephrotic syndrome [8, 23] and
membranous nephropathy [24] in man, as well as in aminonu-
cleoside nephrosis [9], uranyl acetate—induced acute renal fail-
ure [251, and experimental diabetes [261 in animals. In minimal
change nephrotic syndrome in man, foot process widening has
been correlated with serum albumin [8] and the degree of
proteinuria [23] while urinary albumin excretion in aminonucle-
oside nephrosis in rats correlates with foot process width [9]. In
membranous nephropathy, the frequency of filtration slits cor-
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between diabetic patients with and without microalbuminuria.
However, diabetic patients with overt nephropathy were clearly
different from all other groups, and with almost no overlap.
Careful inspection of Figure 4 shows that the statistically
significant correlation between UAE and filtration slit length
density is largely driven by the patients with clinical proteinuria
and that, in the main, two clusters of patients exist. Absolute
filtration slit length per glomerulus shows a less precise rela-
tionship to UAE. This is not surprising since a second param-
eter, that of peripheral capillary filtration surface enters into the
calculation of this measure.
Thus, clearcut changes in epithelial cell structure occur in
type I diabetes only in patients with severe diabetic nephropa-
thology characterized by marked mesangial expansion and
distortion of glomerular capillary architecture, including de-
creased glomerular peripheral capillary filtration surface [11].
We have previously hypothesized that this decrease in surface
could signal adaptive renal responses resulting in hemodynamic
and, possibly, other glomerular alterations which could then
lead to further glomerular injury. It is uncertain as to whether
our measure of filtration slit length per glomerulus or capillary
filtration surface is a better measure of the true surface across
which most of the water flux occurs. Even so, we suppose that
this reduction(s) could be responsible for the epithelial cell
•, changes and the proteinuria seen in advanced diabetic nephrop-
0.7 athy. The exact relationships between proteinuria and epithelial
cell structure, however, remain to be elucidated. Nonetheless,
our work here would argue against glycosylation of glomerular
constituents [27], changes in proteoglycan metabolism [28—30],
or other parallel processes as the sole and direct cause of major
permselectivity defects and epithelial changes in diabetes.
Rather, we argue this is more likely to be consequent to the
mechanical influence of mesangial expansion on filtration sur-
face and the renal adaptations to these perturbations, although
any mechanism alluded to above could play a role in the
mesangial expansion. This argument is consistent with the
observation that the fractional clearances of IgG and albumin as
well as the dextran sieving curves remain normal in diabetic
patients until GFR begins to fall [31]. Then, with progressive
loss of GFR [31] (and thus, filtration surface [11]) there is
progressive disruption of the permselectivity bather.
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